To achieve this, the Tau35 mouse model was utilized alongside the newly generated human neuroblastoma (SH‐SY5Y) cell lines stably expressing either the N‐terminally truncated 35 kDa human tau (187–441) with a C‐terminal HA tag (Tau35) or full‐length (2N4R) human tau with a C‐terminal Avi tag. The gene discussed is MAPT; the disease is neuroblastoma.